Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [3]. Core Insights - The company is expected to achieve revenue growth of 25.1%, 22.7%, and 20.8% for the years 2025, 2026, and 2027, respectively, with net profit growth of 12.3%, 28.4%, and 23.7% during the same period [3]. - The company has a strong market position, being the leading domestic brand in China's pet food market with a market share of 6.2% [3]. - The report highlights the company's continuous product innovation and brand premiumization as key drivers for margin improvement and revenue growth [3][4]. Financial Projections - Revenue projections for the company are as follows: 2023 at 4,327 million, 2024 at 5,245 million, 2025 at 6,559 million, 2026 at 8,049 million, and 2027 at 9,720 million, with respective growth rates of 27.4%, 21.2%, 25.1%, 22.7%, and 20.8% [5]. - Net profit is projected to be 429 million in 2023, 625 million in 2024, 702 million in 2025, 901 million in 2026, and 1,114 million in 2027, with growth rates of 60.7%, 45.7%, 12.3%, 28.4%, and 23.7% [5]. - The gross margin is expected to improve from 36.8% in 2023 to 43.9% in 2027 [5]. Market and Industry Analysis - The pet food market in urban China is projected to reach approximately 158.5 billion in 2024, growing at a rate of 9% year-on-year [3]. - The company has established a dual-brand matrix with its brands, 麦富迪 and 弗列加特, covering a range of products including staple foods, snacks, and health products [3]. - The report notes that the company has been able to maintain a high gross margin due to its focus on high-margin staple foods and direct sales channels, which have increased from 10% in 2018 to 38% in 2024 [3][4].